Private equity returns plummet to lowest levels seen since 2009

Private equity funds returned the lowest amount of cash to investors in a single year since the Great Recession hit 15 years ago, according to Raymond James Financial.

Distributions to such “limited partners” totaled 11.2% of funds’ asset value in 2023. That’s the lowest tally since 2009 and well below the median figure of 25% over the past 25 years, Bloomberg reported Monday.

Volatile markets, economic uncertainty and higher borrowing costs have combined to make it more difficult for PE firms to exit their investments. The median holding period for a buyout firm asset sits at about 5.6 years, much higher than the industry norm of 4 years, according to the report.

“The cash flow math at the investor level is broken,” Sunaina Sinha Haldea, global head of private capital advisory at Raymond James, told Bloomberg. “This is the worst-ever fundraising market, worse than even during the global financial crisis,” she added later.

The news comes amid growing private equity interest across radiology. PE-supported groups in the specialty include Premier Radiology Services, LucidHealth, Radiology Partners, Rayus Radiology, US Radiology Specialists, SimonMed, Solis Mammography and Capitol Imaging.

S&P Global also reported in January that bankruptcies of PE- or venture capital-backed companies hit a record high in 2023. Radiology provider Akumin led the healthcare segment, alongside medical transport firm Air Methods Corp.

Read more from Bloomberg:

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.